Trades on 2 secondary markets

Odyssey Therapeutics

Odyssey Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule and biologic therapeutics for autoimmune, inflammatory, and oncology indications. The company targets upstream immune signaling mechanisms to prevent pathological inflammation rather than only suppressing do

minimal 6.8 / 100 0 APIs View provider profile →

Company Biopharmaceutical Biotechnology Drug Discovery Immunology Oncology

Odyssey Therapeutics is an API provider whose private shares are listed on 2 secondary markets: Forge Global, Hiive.

Where It Trades

F Forge Global View listing → H Hiive View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.